-+ 0.00%
-+ 0.00%
-+ 0.00%

Trevi Therapeutics Reports Positive Phase 2b Results for Nalbuphine ER in IPF Chronic Cough Trial

Reuters·01/22/2026 17:30:16

Please log in to view news